KLRC1 and neoplasm: Consequently, as a logical next step, the anti‐tumor efficacy of intratumoral NK and anti‐NKG2A/Qa‐1b therapy was evaluated in BATF3−/− mice which are devoid of cDC1 cells (Hildner et al, 2008).